Skip to main content
Top
Gepubliceerd in: Quality of Life Research 7/2015

01-07-2015

Role functioning is associated with survival in patients with hepatocellular carcinoma

Auteurs: Adam Meier, Adam Yopp, Huram Mok, Pragathi Kandunoori, Jasmin Tiro, Amit G. Singal

Gepubliceerd in: Quality of Life Research | Uitgave 7/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background

Prior studies assessing quality of life (QOL) in patients with hepatocellular carcinoma (HCC) primarily included patients with preserved liver function and/or early HCC, leading to overestimation of QOL. Our study’s aim was to evaluate the association of QOL with survival among a cohort of cirrhotic patients with HCC that was diverse with respect to liver function and tumor stage.

Methods

We conducted a prospective cohort study among cirrhotic patients with HCC from a large urban safety-net hospital between April 2011 and September 2013. Patients completed two self-administered surveys, the EORTC QLQ-C30 and QLQ-HCC18, prior to the treatment. We used generalized linear models to identify correlates of QOL. Survival curves were generated using Kaplan–Meier analysis and compared using log rank test to determine whether QOL is associated with survival.

Results

A total of 130 treatment-naïve patients completed both surveys. Patients reported high cognitive and social function (median scores 67) but poor global QOL (median score 50) and poor role function (median score 50). QOL was associated with cirrhosis-related (p = 0.02) and tumor-related (p = 0.02) components of Barcelona Clinic Liver Cancer (BCLC) tumor stage. QOL was associated with survival on univariate analysis (HR 0.37, 95 % CI 0.16–0.85) but became nonsignificant (HR 0.82, 95 % CI 0.37–1.80) after adjusting for BCLC stage and treatment. Role functioning was significantly associated with survival (HR 0.40, 95 % CI 0.20–0.81), after adjusting for Caucasian race (HR 0.31, 95 % CI 0.16–0.59), BCLC stage (HR 1.51, 95 % CI 0.21–1.89), and treatment (HR 0.57, 95 % CI 0.33–0.97).

Conclusions

Role function has prognostic significance and is important to assess in patients with HCC.
Literatuur
1.
go back to reference El-Serag, H. B. (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142(1264–1273), e1261. El-Serag, H. B. (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142(1264–1273), e1261.
2.
go back to reference El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003). The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Annals of Internal Medicine, 139, 817–823.PubMedCrossRef El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003). The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Annals of Internal Medicine, 139, 817–823.PubMedCrossRef
3.
go back to reference Bruix, J., & Sherman, M. (2010). Management of hepatocellular carcinoma: An update. Hepatology, 53, 1–35.CrossRef Bruix, J., & Sherman, M. (2010). Management of hepatocellular carcinoma: An update. Hepatology, 53, 1–35.CrossRef
4.
go back to reference Altekruse, S. F., McGlynn, K. A., Dickie, L. A., & Kleiner, D. E. (2012). Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992–2008. Hepatology, 55, 476–482.PubMedCrossRef Altekruse, S. F., McGlynn, K. A., Dickie, L. A., & Kleiner, D. E. (2012). Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992–2008. Hepatology, 55, 476–482.PubMedCrossRef
5.
go back to reference Tan, D., Yopp, A., Beg, M. S., Gopal, P., & Singal, A. G. (2013). Meta-analysis: Underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States. Alimentary Pharmacology & Therapeutics, 38, 703–712.CrossRef Tan, D., Yopp, A., Beg, M. S., Gopal, P., & Singal, A. G. (2013). Meta-analysis: Underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States. Alimentary Pharmacology & Therapeutics, 38, 703–712.CrossRef
6.
go back to reference Singal, A. G., Waljee, A. K., Patel, N., Chen, E. Y., Tiro, J. A., et al. (2013). Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. Journal of the National Comprehensive Cancer Network, 11, 1101–1108.PubMed Singal, A. G., Waljee, A. K., Patel, N., Chen, E. Y., Tiro, J. A., et al. (2013). Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. Journal of the National Comprehensive Cancer Network, 11, 1101–1108.PubMed
7.
go back to reference Singal, A. G., Conjeevaram, H. S., Volk, M. L., Fu, S., Fontana, R. J., et al. (2012). Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prevention, 21, 793–799.CrossRef Singal, A. G., Conjeevaram, H. S., Volk, M. L., Fu, S., Fontana, R. J., et al. (2012). Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prevention, 21, 793–799.CrossRef
8.
go back to reference Singal, A. G., Nehra, M., Adams-Huet, B., Yopp, A. C., Tiro, J. A., et al. (2013). Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: Where did surveillance fail? American Journal of Gastroenterology, 108, 425–432.PubMedCrossRef Singal, A. G., Nehra, M., Adams-Huet, B., Yopp, A. C., Tiro, J. A., et al. (2013). Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: Where did surveillance fail? American Journal of Gastroenterology, 108, 425–432.PubMedCrossRef
9.
10.
go back to reference Singal, A. G., Yopp, A., Skinner, C. S., Packer, M., Lee, W. M., et al. (2012). Utilization of hepatocellular carcinoma surveillance among American patients: A systematic review. Journal of General Internal Medicine, 27, 861–867.PubMedCentralPubMedCrossRef Singal, A. G., Yopp, A., Skinner, C. S., Packer, M., Lee, W. M., et al. (2012). Utilization of hepatocellular carcinoma surveillance among American patients: A systematic review. Journal of General Internal Medicine, 27, 861–867.PubMedCentralPubMedCrossRef
11.
go back to reference Bonnetain, F., Paoletti, X., Collette, S., Doffoel, M., Bouche, O., et al. (2008). Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: Results from two French clinical trials. Quality of Life Research, 17, 831–843.PubMedCrossRef Bonnetain, F., Paoletti, X., Collette, S., Doffoel, M., Bouche, O., et al. (2008). Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: Results from two French clinical trials. Quality of Life Research, 17, 831–843.PubMedCrossRef
12.
go back to reference Diouf, M., Filleron, T., Barbare, J. C., Fin, L., Picard, C., et al. (2013). The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma. Journal of Hepatology, 58, 509–521.PubMedCrossRef Diouf, M., Filleron, T., Barbare, J. C., Fin, L., Picard, C., et al. (2013). The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma. Journal of Hepatology, 58, 509–521.PubMedCrossRef
13.
go back to reference Yeo, W., Mo, F. K., Koh, J., Chan, A. T., Leung, T., et al. (2006). Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Annals of Oncology, 17, 1083–1089.PubMedCrossRef Yeo, W., Mo, F. K., Koh, J., Chan, A. T., Leung, T., et al. (2006). Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Annals of Oncology, 17, 1083–1089.PubMedCrossRef
14.
go back to reference Kondo, Y., Yoshida, H., Tateishi, R., Shiina, S., Mine, N., et al. (2007). Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. Journal of Gastroenterology and Hepatology, 22, 197–203.PubMedCrossRef Kondo, Y., Yoshida, H., Tateishi, R., Shiina, S., Mine, N., et al. (2007). Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. Journal of Gastroenterology and Hepatology, 22, 197–203.PubMedCrossRef
15.
go back to reference Steel, J. L., Chopra, K., Olek, M. C., & Carr, B. I. (2007). Health-related quality of life: Hepatocellular carcinoma, chronic liver disease, and the general population. Quality of Life Research, 16, 203–215.PubMedCrossRef Steel, J. L., Chopra, K., Olek, M. C., & Carr, B. I. (2007). Health-related quality of life: Hepatocellular carcinoma, chronic liver disease, and the general population. Quality of Life Research, 16, 203–215.PubMedCrossRef
16.
go back to reference Bianchi, G., Loguercio, C., Sgarbi, D., Abbiati, R., Brunetti, N., et al. (2003). Reduced quality of life of patients with hepatocellular carcinoma. Digestive and Liver Disease, 35, 46–54.PubMedCrossRef Bianchi, G., Loguercio, C., Sgarbi, D., Abbiati, R., Brunetti, N., et al. (2003). Reduced quality of life of patients with hepatocellular carcinoma. Digestive and Liver Disease, 35, 46–54.PubMedCrossRef
17.
go back to reference Fan, S. Y., Eiser, C., & Ho, M. C. (2010). Health-related quality of life in patients with hepatocellular carcinoma: A systematic review. Clinical Gastroenterol and Hepatology, 8(7), 559–564.CrossRef Fan, S. Y., Eiser, C., & Ho, M. C. (2010). Health-related quality of life in patients with hepatocellular carcinoma: A systematic review. Clinical Gastroenterol and Hepatology, 8(7), 559–564.CrossRef
18.
go back to reference Les, I., Doval, E., Flavia, M., Jacas, C., Cardenas, G., et al. (2010). Quality of life in cirrhosis is related to potentially treatable factors. European Journal of Gastroenterology and Hepatology, 22, 221–227.PubMedCrossRef Les, I., Doval, E., Flavia, M., Jacas, C., Cardenas, G., et al. (2010). Quality of life in cirrhosis is related to potentially treatable factors. European Journal of Gastroenterology and Hepatology, 22, 221–227.PubMedCrossRef
19.
go back to reference Mikoshiba, N., Miyashita, M., Sakai, T., Tateishi, R., & Koike, K. (2013). Depressive symptoms after treatment in hepatocellular carcinoma survivors: Prevalence, determinants, and impact on health-related quality of life. Psycho-Oncology, 22(10), 2347–2353.PubMed Mikoshiba, N., Miyashita, M., Sakai, T., Tateishi, R., & Koike, K. (2013). Depressive symptoms after treatment in hepatocellular carcinoma survivors: Prevalence, determinants, and impact on health-related quality of life. Psycho-Oncology, 22(10), 2347–2353.PubMed
20.
go back to reference Blazeby, J. M., Currie, E., Zee, B. C., Chie, W. C., Poon, R. T., et al. (2004). Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. European Journal of Cancer, 40, 2439–2444.PubMedCrossRef Blazeby, J. M., Currie, E., Zee, B. C., Chie, W. C., Poon, R. T., et al. (2004). Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. European Journal of Cancer, 40, 2439–2444.PubMedCrossRef
21.
go back to reference Chie, W. C., Blazeby, J. M., Hsiao, C. F., Chiu, H. C., Poon, R. T., et al. (2012). International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18. Hepatology, 55, 1122–1129.PubMedCrossRef Chie, W. C., Blazeby, J. M., Hsiao, C. F., Chiu, H. C., Poon, R. T., et al. (2012). International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18. Hepatology, 55, 1122–1129.PubMedCrossRef
22.
go back to reference Yopp, A. C., Mansour, J. C., Beg, M. S., Arenas, J., Trimmer, C., et al. (2013). Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Annals of Surgical Oncology, 21(4), 1287–1295.PubMedCrossRef Yopp, A. C., Mansour, J. C., Beg, M. S., Arenas, J., Trimmer, C., et al. (2013). Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Annals of Surgical Oncology, 21(4), 1287–1295.PubMedCrossRef
23.
go back to reference Singal, A. G., Yopp, A. C., Gupta, S., Skinner, C. S., Halm, E. A., et al. (2012). Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prevention Research, 5, 1124–1130.PubMedCentralPubMedCrossRef Singal, A. G., Yopp, A. C., Gupta, S., Skinner, C. S., Halm, E. A., et al. (2012). Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prevention Research, 5, 1124–1130.PubMedCentralPubMedCrossRef
24.
go back to reference de Borja, M. T., Chow, E., Bovett, G., Davis, L., & Gillies, C. (2004). The correlation among patients and health care professionals in assessing functional status using the karnofsky and eastern cooperative oncology group performance status scales. Support Cancer Therapy, 2, 59–63.CrossRef de Borja, M. T., Chow, E., Bovett, G., Davis, L., & Gillies, C. (2004). The correlation among patients and health care professionals in assessing functional status using the karnofsky and eastern cooperative oncology group performance status scales. Support Cancer Therapy, 2, 59–63.CrossRef
25.
go back to reference de Kock, I., Mirhosseini, M., Lau, F., Thai, V., Downing, M., et al. (2013). Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools. Journal of Palliative Care, 29, 163–169.PubMed de Kock, I., Mirhosseini, M., Lau, F., Thai, V., Downing, M., et al. (2013). Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools. Journal of Palliative Care, 29, 163–169.PubMed
26.
go back to reference Cillo, U., Vitale, A., Grigoletto, F., Farinati, F., Brolese, A., et al. (2006). Prospective validation of the Barcelona Clinic Liver Cancer staging system. Journal of Hepatology, 44, 723–731.PubMedCrossRef Cillo, U., Vitale, A., Grigoletto, F., Farinati, F., Brolese, A., et al. (2006). Prospective validation of the Barcelona Clinic Liver Cancer staging system. Journal of Hepatology, 44, 723–731.PubMedCrossRef
27.
28.
go back to reference Chan, A. O., Yuen, M. F., Hui, C. K., Tso, W. K., & Lai, C. L. (2002). A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer, 94, 1747–1752.PubMedCrossRef Chan, A. O., Yuen, M. F., Hui, C. K., Tso, W. K., & Lai, C. L. (2002). A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer, 94, 1747–1752.PubMedCrossRef
29.
go back to reference Donaghy, A. (2002). Issues of malnutrition and bone disease in patients with cirrhosis. Journal of Gastroenterology and Hepatology, 17, 462–466.PubMedCrossRef Donaghy, A. (2002). Issues of malnutrition and bone disease in patients with cirrhosis. Journal of Gastroenterology and Hepatology, 17, 462–466.PubMedCrossRef
Metagegevens
Titel
Role functioning is associated with survival in patients with hepatocellular carcinoma
Auteurs
Adam Meier
Adam Yopp
Huram Mok
Pragathi Kandunoori
Jasmin Tiro
Amit G. Singal
Publicatiedatum
01-07-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 7/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-014-0895-1

Andere artikelen Uitgave 7/2015

Quality of Life Research 7/2015 Naar de uitgave